J&J, International Partnership for Microbicides deal

Johnson & Johnson's Janssen R&D Ireland unit granted the not-for-profit exclusive, worldwide rights to develop and commercialize dapivirine under an expanded 2004 deal. IPM gained a royalty-free licen...